These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 19502377)

  • 21. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems.
    Lee NY; Wu JJ; Lin SH; Ko WC; Tsai LH; Yan JJ
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1941-50. PubMed ID: 22249422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia.
    Uz Zaman T; Aldrees M; Al Johani SM; Alrodayyan M; Aldughashem FA; Balkhy HH
    Int J Infect Dis; 2014 Nov; 28():186-92. PubMed ID: 25245001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
    Wienke M; Pfeifer Y; Weissgerber P; Marschal M; Autenrieth IB; Gröbner S
    Chemotherapy; 2012; 58(3):241-8. PubMed ID: 22832033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling.
    Tian X; Wang Q; Perlaza-Jiménez L; Zheng X; Zhao Y; Dhanasekaran V; Fang R; Li J; Wang C; Liu H; Lithgow T; Cao J; Zhou T
    BMC Microbiol; 2020 Jul; 20(1):218. PubMed ID: 32689945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
    Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
    BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spread of Klebsiella pneumoniae ST395 non-susceptible to carbapenems and resistant to fluoroquinolones in North-Eastern France.
    Muggeo A; Guillard T; Klein F; Reffuveille F; François C; Babosan A; Bajolet O; Bertrand X; de Champs C;
    J Glob Antimicrob Resist; 2018 Jun; 13():98-103. PubMed ID: 29113933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porin alterations present in non-carbapenemase-producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile.
    Wozniak A; Villagra NA; Undabarrena A; Gallardo N; Keller N; Moraga M; Román JC; Mora GC; García P
    J Med Microbiol; 2012 Sep; 61(Pt 9):1270-1279. PubMed ID: 22700549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
    Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L
    Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emergence of bla
    Moghadampour M; Rezaei A; Faghri J
    Acta Microbiol Immunol Hung; 2018 Aug; 65(3):335-344. PubMed ID: 30024268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
    J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
    Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
    J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular insights of Carbapenem resistance Klebsiella pneumoniae isolates with focus on multidrug resistance from clinical samples.
    Indrajith S; Mukhopadhyay AK; Chowdhury G; Farraj DAA; Alkufeidy RM; Natesan S; Meghanathan V; Gopal S; Muthupandian S
    J Infect Public Health; 2021 Jan; 14(1):131-138. PubMed ID: 33234410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-lactam resistance associated with β-lactamase production and porin alteration in clinical isolates of E. coli and K. pneumoniae.
    Khalifa SM; Abd El-Aziz AM; Hassan R; Abdelmegeed ES
    PLoS One; 2021; 16(5):e0251594. PubMed ID: 34014957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
    Samra Z; Ofir O; Lishtzinsky Y; Madar-Shapiro L; Bishara J
    Int J Antimicrob Agents; 2007 Dec; 30(6):525-9. PubMed ID: 17931835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
    Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1.
    Datta S; Roy S; Chatterjee S; Saha A; Sen B; Pal T; Som T; Basu S
    PLoS One; 2014; 9(11):e112101. PubMed ID: 25406074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.